|
|
 |
|
Viewing report
|
|
|
|
Smoking Cessation Aids - Global Strategic Business Report
Global Industry Analysts, Inc., April 2008, Pages: 218
This report analyzes the worldwide markets for Smoking Cessation Aids in US$ Million. The major product segments analyzed are Nicotine Gum, Nicotine Patch, Nicotine lozenges & tablets, and Others (Nicotine Inhaler, and Nasal Spray). The report provides separate comprehensive analytics for the US, Canada, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 32 companies including many key and niche players worldwide such as GlaxoSmithKline Plc, Johnson & Johnson Inc., Novartis Consumer Healthcare Inc., Perrigo Company, and Pfizer Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying
Customers who bought this item also bought
NRT Smoking Cessation Aids in the US
Smoking Cessation Aids in the United States
Cigarettes and Smoking Cessation Aids in the United States 2008
Snapshots UK Smoking Cessation Aids 2007
Nrt Smoking Cessation Aids in Finland
Nrt Smoking Cessation Aids in Denmark
Nrt Smoking Cessation Aids in Romania
NRT Smoking Cessation Aids in Slovakia
NRT Smoking Cessation Aids in Morocco
Nrt Smoking Cessation Aids in Mexico
Pipeline and Commercial Insight: Nicotine Dependence - Chantix issues overshadow vaccine potential
NRT Smoking Cessation Aids in Taiwan
|
|
|
|
